Recurrence of ovarian cancer as a delayed solitary parenchymal splenic metastasis

International Journal of Gynecological Cancer

Volumn 6, Issue 6, 1996, Pages 496-498

  Balat, O ^a   Verschraegen, C ^a   Erbilen, M ^b   Edwards, C L ^a   Silva, E ^a   Kudelka, A P ^a   Kavanagh, J J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b INONU UNIVERSITY   (Turkey)

Author keywords

ovarian cancer; solitary metastasis; spleen

Indexed keywords

ABDOMINAL HYSTERECTOMY; AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; FEMALE; HUMAN; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SPLEEN CANCER; SPLENECTOMY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0029819298     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1996.06060496.x     Document Type: Article

References (16)

1. Dauplat J, Hacker NF, Nieberg RK, Berek JS, Rose TP, Sagae S. Distant metastases in epithelial ovarian carcinoma. Cancer 1987; 60: 1561-6.
2. Nelson BE, Rose PG, Reale FR. Isolated parenchymal splenic metastasis in epithelial ovarian cancer. Gynecol Oncol 1993; 50: 124-7.
3. Eisner RF, Braly P, Berek JS. Solitary recurrent metastasis of epithelial ovarian cancer in the spleen. Gynecol Oncol 1993; 48: 338-41.
4. Morgenstern L, Rosenberg J, Lau T. Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer 1989; 64: 1508-13.
5. Minagawa Y, Kanamori Y, Ishihara H, et al. Solitary metastatic ovarian carcinoma of the spleen: A case report. Asia-Oceania J Obstet Gynecol 1991; 17: 45-8.
6. Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994; 70: 974-80.
7. Ozols RF, Rubin SC, Dembo AJ, Robboy S. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology. Philadelphia: JB Lippincott, 1992; 731-81.
8. William Creasman. Second look laparatomy in ovarian cancer. Gynecol Oncol 1994; 55: S122-7.
9. Podratz KC, Schray MF, Wieand HS, et al. Evaluation of treatment and survival after positive second look laparotomy. Gynecol Oncol 1989; 31: 9-24.
10. Hoskins WJ, Rubin SC, Dulaney E, et al. Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma. Gynecol Oncol 1989; 34: 365-71.
11. Lippman SM, Alberts DS, Slymen DJ, et al. Second-look laparotomy in epithelial ovarian carcinoma: Prognostic factors associated with survival duration. Cancer 1988; 61: 2571-77.
12. Morris M, Gershenson DM, Burke TW, Wharton JT, Copeland LJ, Rutledge FN. Splenectomy in gynecologic oncology: indications, complications and technique. Gynecol Oncol 1991; 43: 118-22.
13. Deppe G, Zbella EA, Skogerson K, Dumitru I. The rare indication for splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol 1983; 16: 282-7.
14. Cole JT, Flaum MA. Postsplenectomy infections. Southern Med J 1992; 85(12): 1220-6.
15. Bailey CT, Powderly WG. Treatment of infectious disease. In: Woodley M, Whelan A, eds. Manual of Medical Therapeutics 27th edn. Boston: Little, Brown, 1992; 250-80.
16. Recommendations of the immunization practices advisory committee (ACIP). Pneumococcal polysacharide vaccine. MMWR 1989; 38: 64.